Structure-activity relationships virtual screening

Flohr S, Kurz M, Kostenis E, Brkovich A, Fournier A, Klabunde T. Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure-activity relationships and nuclear magnetic resonance studies on urotensin II. J Med Ghent 2002 45 1799-805. 

In this chapter, we will give a brief introduction to the basic concepts of chemoinformatics and their relevance to chemical library design. In Section 2, we will describe chemical representation, molecular data, and molecular data mining in computer we will introduce some of the chemoinformatics concepts such as molecular descriptors, chemical space, dimension reduction, similarity and diversity and we will review the most useful methods and applications of chemoinformatics, the quantitative structure-activity relationship (QSAR), the quantitative structure-property relationship (QSPR), multiobjective optimization, and virtual screening. In Section 3, we will outline some of the elements of library design and connect chemoinformatics tools, such as molecular similarity, molecular diversity, and multiple objective optimizations, with designing optimal libraries. Finally, we will put library design into perspective in Section 4. 

Peterson, Y. K., Wang, X. S., Casey, P. J., Tropsha, A. (2009) Discovery of geranylgeranyltransferase-I inhibitors with novel scaffolds by the means of quantitative structure-activity relationship modeling, virtual screening, and experimental validation. J Med Chem 52, 4210-4220. 

One may think of an iterative model for the preclinical discovery screening cycle. A large number of compounds are to be mined for compounds that are active for example, that bind to a particular target. The compounds may come from different sources such as vendor catalogues, corporate collections, or combinatorial chemistry projects. In fact, the compounds need only to exist in a virtual sense, because in silico predictions in the form of a model can be made in a virtual screen (Section 8) which can then be used to decide which compounds should be physically made and tested. A mapping from the structure space of compounds to the descriptor space or property space provides covariates or explanatory variables that can be used to build predictive models. These models can help in the selection process, where a subset of available molecules is chosen for the biological screen. The experimental results of the biological screen (actives and inactives, or numeric potency values) are then used to learn more about the structure-activity relationship (SAR) which leads to new models and a new selection of compounds as the cycle renews. 

---